{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:09:41Z","timestamp":1781518181737,"version":"3.54.1"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s12519-010-0002-9","type":"journal-article","created":{"date-parts":[[2010,2,8]],"date-time":"2010-02-08T05:04:33Z","timestamp":1265605473000},"page":"13-31","source":"Crossref","is-referenced-by-count":20,"title":["Advances in diagnosis and treatment of pulmonary arterial hypertension in neonates and children with congenital heart disease"],"prefix":"10.1007","volume":"6","author":[{"given":"Monnipa","family":"Suesaowalak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Cleary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony C.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,9]]},"reference":[{"key":"2_CR1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0031-3955(05)70121-8","volume":"46","author":"R.J. Barst","year":"1999","unstructured":"Barst RJ. Recent advances in the treatment of pediatric pulmonary artery hypertension. Pediatr Clin North Am 1999;46: 331\u2013345.","journal-title":"Pediatr Clin North Am"},{"key":"2_CR2","doi-asserted-by":"crossref","first-page":"40S","DOI":"10.1016\/j.jacc.2004.02.032","volume":"43","author":"R.J. Barst","year":"2004","unstructured":"Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43: 40S\u201347S.","journal-title":"J Am Coll Cardiol"},{"key":"2_CR3","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra035488","volume":"351","author":"H.W. Farber","year":"2004","unstructured":"Farber HW, Loscalzo J. Mechanisms of disease: pulmonary arterial hypertension. N Engl J Med 2004;351:1655\u20131665.","journal-title":"N Engl J Med"},{"key":"2_CR4","doi-asserted-by":"crossref","first-page":"ep15","DOI":"10.1136\/adc.2002.018937","volume":"90","author":"K. Ford","year":"2005","unstructured":"Ford K. Pulmonary artery hypertension: new drug treatment in children. Arch Dis Child Ed Pract 2005;90:ep15\u2013ep20.","journal-title":"Arch Dis Child Ed Pract"},{"key":"2_CR5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1183\/09031936.03.00088302","volume":"21","author":"A. Widlitz","year":"2003","unstructured":"Widlitz A, Barst RJ. Pulmonary arterial hypertension in children. Eur Respir J 2003;21:155\u2013176.","journal-title":"Eur Respir J"},{"key":"2_CR6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.21693\/1933-088X-6.3.121","volume":"6","author":"I. Schulze-Neick","year":"2007","unstructured":"Schulze-Neick I, Deanfield JE. Pulmonary arterial hypertension in adults with congenital heart disease: general overview of disease mechanisms. Adv Pulmonary Hypertens 2007;6: 121\u2013125.","journal-title":"Adv Pulmonary Hypertens"},{"key":"2_CR7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.prrv.2005.06.010","volume":"6","author":"R.M. Tulloh","year":"2005","unstructured":"Tulloh RM. Congenital heart disease in relation to pulmonary hypertension in paediatric practice. Paediatr Respir Rev 2005;6: 174\u2013180.","journal-title":"Paediatr Respir Rev"},{"key":"2_CR8","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/j.jacc.2004.02.037","volume":"43","author":"G. Simonneau","year":"2004","unstructured":"Simonneau G, Gali\u00e8 N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004;43:5S\u201312S.","journal-title":"J Am Coll Cardiol"},{"key":"2_CR9","first-page":"11","volume-title":"Pulmonary arterial hypertension related to congenital heart disease","author":"N. Gali\u00e8","year":"2006","unstructured":"Gali\u00e8 N. Classification of patients with congenital systemicto-pulmonary shunts associated with pulmonary arterial hypertension: current status and future directions. In: Beghetti M, Barst RJ, Naeije R, Rubin LJ, eds. Pulmonary arterial hypertension related to congenital heart disease. Munich (Germany): Elsevier GmbH Deutschland, 2006: 11\u201317."},{"key":"2_CR10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1017\/S1047951107001849","volume":"18","author":"M.E. Albada van","year":"2008","unstructured":"van Albada ME, Berger RM. Pulmonary arterial hypertension in congenital cardiac disease\u2014the need for refinement of the Evian-Vanice classification. Cardiol Young 2008;18:10\u201317.","journal-title":"Cardiol Young"},{"key":"2_CR11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1017\/S1047951107001850","volume":"18","author":"I. Schulze-Neick","year":"2008","unstructured":"Schulze-Neick I, Beghetti M. Classifying pulmonary hypertension in the setting of the congenitally malformed heart\u2014cleaning up a dog\u2019s dinner. Cardiol Young 2008;18: 22\u201325.","journal-title":"Cardiol Young"},{"key":"2_CR12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/01.CIR.18.4.533","volume":"18","author":"D. Heath","year":"1958","unstructured":"Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease: a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 1958; 18:533\u2013547.","journal-title":"Circulation"},{"key":"2_CR13","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1253\/jcj.64.909","volume":"64","author":"K. Nagumo","year":"2000","unstructured":"Nagumo K, Yamaki S, Takahashi T. Extremely thickened media of small pulmonary arteries in fatal pulmonary hypertension with congenital heart disease\u2014a morphometric and clinicopathological study. Jpn Circ J 2000;64:909\u2013914.","journal-title":"Jpn Circ J"},{"key":"2_CR14","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1161\/01.CIR.58.6.1107","volume":"58","author":"M. Rabinovitch","year":"1978","unstructured":"Rabinovitch M, Haworth SG, Castaneda AR, Nadas AS, Reid LM. Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease. Circulation 1978;58:1107\u20131122.","journal-title":"Circulation"},{"key":"2_CR15","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1161\/01.CIR.69.4.655","volume":"69","author":"M. Rabinovitch","year":"1984","unstructured":"Rabinovitch M, Keane JF, Norwood WI, Castaneda AR, Reid L. Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects. Circulation 1984;69:655\u2013667.","journal-title":"Circulation"},{"key":"2_CR16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0002-9149(82)90332-0","volume":"50","author":"W.F. Friedman","year":"1982","unstructured":"Friedman WF, Heiferman MF. Clinical problems of postoperative pulmonary vascular disease. Am J Cardiol 1982; 50:631\u2013636.","journal-title":"Am J Cardiol"},{"key":"2_CR17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/hrt.52.5.557","volume":"52","author":"S.G. Haworth","year":"1984","unstructured":"Haworth SG. Pulmonary vascular disease in different types of congenital heart disease: implications for interpretation of lung biopsy findings in early childhood. Br Heart J 1984;52:557\u2013571.","journal-title":"Br Heart J"},{"key":"2_CR18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1620\/tjem.182.83","volume":"182","author":"S. Yamaki","year":"1997","unstructured":"Yamaki S, Endo M, Takahashi T. Different grades of medial hypertrophy and intimal changes in small pulmonary arteries among various types of congenital heart disease with pulmonary hypertension. Tohoku J Exp Med 1997;182:83\u201391.","journal-title":"Tohoku J Exp Med"},{"key":"2_CR19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ccm.2006.12.004","volume":"28","author":"M.J. Landzberg","year":"2007","unstructured":"Landzberg MJ. Congenital heart disease associated pulmonary arterial hypertension. Clin Chest Med 2007;28:243\u2013253.","journal-title":"Clin Chest Med"},{"key":"2_CR20","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1378\/chest.77.5.614","volume":"77","author":"C.A. Wagenvoort","year":"1980","unstructured":"Wagenvoort CA. Lung biopsy specimens in the evaluation of pulmonary vascular disease. Chest 1980;77:614\u2013625.","journal-title":"Chest"},{"key":"2_CR21","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/S0003-4975(98)00776-0","volume":"66","author":"S. Yamaki","year":"1998","unstructured":"Yamaki S, Abe A, Endo M, Tanaka T, Tabayashi K, Takahashi T. Surgical indication for congenital heart disease with extremely thickened media of small pulmonary arteries. Ann Thorac Surg 1998;66:1560\u20131564.","journal-title":"Ann Thorac Surg"},{"key":"2_CR22","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0003-4975(98)00779-6","volume":"66","author":"S. Yamaki","year":"1998","unstructured":"Yamaki S, Abe A, Tabayashi K, Endo M, Mohri H, Takahashi T. Inoperable pulmonary vascular disease in infants with congenital heart disease. Ann Thorac Surg 1998;66:1565\u20131570.","journal-title":"Ann Thorac Surg"},{"key":"2_CR23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1078\/0344-0338-00457","volume":"199","author":"E.S. Egito","year":"2003","unstructured":"Egito ES, Aiello VD, Bosisio IB, Lichtenfels AJ, Horta AL, Saldiva PH, et al. Vascular remodeling process in reversibility of pulmonary arterial hypertension secondary to congenital heart disease. Pathol Res Pract 2003;199:521\u2013532.","journal-title":"Pathol Res Pract"},{"key":"2_CR24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3109\/15513818309025874","volume":"1","author":"B. Alt","year":"1983","unstructured":"Alt B, Shikes RH. Pulmonary hypertension in congenital heart disease: irreversible vascular changes in young infants. Pediatr Pathol 1983;1:423\u2013434.","journal-title":"Pediatr Pathol"},{"key":"2_CR25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.7326\/0003-4819-148-4-200802190-00006","volume":"148","author":"J.H. Newman","year":"2008","unstructured":"Newman JH, Phillips JA 3rd, Loyd JE. Narrative review: the enigma of pulmonary arterial hypertension: new insights from genetic studies. Ann Intern Med 2008;148:278\u2013283.","journal-title":"Ann Intern Med"},{"key":"2_CR26","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1183\/09031936.04.00018604","volume":"24","author":"K.E. Roberts","year":"2004","unstructured":"Roberts KE, McElroy JJ, Wong WP, Yen E, Widlitz A, Barst RJ, et al. BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease. Eur Respir J 2004;24:371\u2013374.","journal-title":"Eur Respir J"},{"key":"2_CR27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1203\/00006450-200107000-00007","volume":"50","author":"A. Limsuwan","year":"2001","unstructured":"Limsuwan A, Platoshyn O, Yu Y, Rubin LJ, Rothman A, Yuan JX. Inhibition of K(+) channel activity in human pulmonary artery smooth muscle cells by serum from patients with pulmonary hypertension secondary to congenital heart disease. Pediatr Res 2001;50:23\u201328.","journal-title":"Pediatr Res"},{"key":"2_CR28","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/j.jacc.2004.02.029","volume":"43","author":"M. Humbert","year":"2004","unstructured":"Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43: 13S\u201324S.","journal-title":"J Am Coll Cardiol"},{"key":"2_CR29","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/CIRCULATIONAHA.105.592386","volume":"115","author":"G.P. Diller","year":"2007","unstructured":"Diller GP, Gatzoulis MA. Pulmonary vascular disease in adults with congenital heart disease. Circulation 2007;115:1039\u20131050.","journal-title":"Circulation"},{"key":"2_CR30","first-page":"1355","volume-title":"Moss and Adams\u2019 heart disease in infants, children, and adolescents including the fetus and young adult","author":"E.B. Rosenzweig","year":"2008","unstructured":"Rosenzweig EB, Barst RJ. Clinical management of patients with pulmonary hypertension. In: Allen HD, Driscoll DJ, Shaddy RE, Feltes TF, eds. Moss and Adams\u2019 heart disease in infants, children, and adolescents including the fetus and young adult, 7th ed. Philadelphia: Lippincott Williams & Wilkins, 2008: 1355\u20131368.","edition":"7th ed"},{"key":"2_CR31","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1053\/euhj.1998.1046","volume":"19","author":"L. Daliento","year":"1998","unstructured":"Daliento L, Somerville J, Presbitero P, Menti L, Brach-Prever S, Rizzoli G, et al. Eisenmenger syndrome: factors relating to deterioration and death. Eur Heart J 1998;19:1845\u20131855.","journal-title":"Eur Heart J"},{"key":"2_CR32","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/hrt.2004.051789","volume":"91","author":"M. Gewillig","year":"2005","unstructured":"Gewillig M. The Fontan circulation. Heart 2005;91:839\u2013846.","journal-title":"Heart"},{"key":"2_CR33","first-page":"503","volume":"83","author":"M.A. Santos","year":"2004","unstructured":"Santos MA, Azevedo VM. Anomalous origin of one pulmonary artery from the ascending aorta. Surgical repair resolving pulmonary arterial hypertension. Arq Bras Cardiol 2004; 83:503\u2013507.","journal-title":"Arq Bras Cardiol"},{"key":"2_CR34","first-page":"1322","volume-title":"Moss and Adams\u2019 heart disease in infants, children, and adolescents including the fetus and young adult","author":"M. Robinovitch","year":"2008","unstructured":"Robinovitch M. Pathophysiology of pulmonary hypertension. In: Allen HD, Driscoll DJ, Shaddy RE, Feltes TF, eds. Moss and Adams\u2019 heart disease in infants, children, and adolescents including the fetus and young adult, 7th ed. Philadelphia: Lippincott Williams & Wilkins, 2008: 1322\u20131354.","edition":"7th ed."},{"key":"2_CR35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1054-8807(02)00105-9","volume":"11","author":"L. Daliento","year":"2002","unstructured":"Daliento L, Rebellato L, Angelini A, Frescura C, Mazzotti E, Rotundo M, et al. Fatal outcome in Eisenmenger syndrome. Cardiovasc Pathol 2002;11:221\u2013228.","journal-title":"Cardiovasc Pathol"},{"issue":"Suppl1","key":"2_CR36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1017\/S1047951109003874","volume":"19","author":"A.C. Chang","year":"2009","unstructured":"Chang AC, Macrae D. Neonates with congenital cardiac defects and pulmonary hypertension. Cardiol Young 2009;19(Suppl 1):4\u20137.","journal-title":"Cardiol Young"},{"key":"2_CR37","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/B978-032301281-2.50048-5","volume-title":"Critical heart disease in infants and children","author":"A.M. Murphy","year":"2006","unstructured":"Murphy AM, Neill CA, Zuckerberg AL. Syndromes and congenital heart defects. In: Nichols DG, Ungerleider RM, Spevak PJ, Greeley WJ, Cameron DE, Lappe DG, et al (eds). Critical heart disease in infants and children, 2nd ed. Philadelphia: Elsevier, 2006: 951\u2013971.","edition":"2nd ed"},{"key":"2_CR38","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/1522-726X(200101)52:1<49::AID-CCD1012>3.0.CO;2-0","volume":"52","author":"L.J. Kajita","year":"2001","unstructured":"Kajita LJ, Martinez EE, Ambrose JA, Lemos PA, Esteves A, Nogueira da Gama M, et al. Extrinsic compression of the left main coronary artery by a dilated pulmonary artery: clinical, angiographic, and hemodynamic determinants. Catheter Cardiovasc Interv 2001;52:49\u201354.","journal-title":"Catheter Cardiovasc Interv"},{"key":"2_CR39","first-page":"E102","volume":"18","author":"Y. Pi\u00f1a","year":"2006","unstructured":"Pi\u00f1a Y, Exaire JE, Sandoval J. Left main coronary artery extrinsic compression syndrome: a combined intravascular ultrasound and pressure wire. J Invasive Cardiol 2006;18: E102\u2013104.","journal-title":"J Invasive Cardiol"},{"key":"2_CR40","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.ijcard.2006.12.043","volume":"118","author":"F.A. Pa\u00e7","year":"2007","unstructured":"Pa\u00e7 FA, Ca\u011fdas DN, Ula\u015f M, Ozatik MA, Pa\u00e7 M. Left main coronary artery and aortic root compression associated with atrial septal defect and pulmonary hypertension. Int J Cardiol 2007;118:e41\u201343.","journal-title":"Int J Cardiol"},{"key":"2_CR41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4065\/84.2.191","volume":"84","author":"M.D. McGoon","year":"2009","unstructured":"McGoon MD, Kane GC. Pulmonary hypertension: diagnosis and management. Mayo Clin Proc 2009;84:191\u2013207.","journal-title":"Mayo Clin Proc"},{"key":"2_CR42","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1148\/radiographics.9.5.2678297","volume":"9","author":"P.A. Randall","year":"1989","unstructured":"Randall PA, Heitzman ER, Bull MJ, Scalzetti EM, Williams SK, Gordon LP, et al. Pulmonary arterial hypertension: a contemporary review. Radiographics 1989;9:905\u2013927.","journal-title":"Radiographics"},{"key":"2_CR43","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0735-1097(85)80433-2","volume":"5","author":"T. Ryan","year":"1985","unstructured":"Ryan T, Petrovic O, Dillon JC, Feigenbaum H, Conley MJ, Armstrong WF. An echocardiographic index for separation of right ventricular volume and pressure overload. J Am Coll Cardiol 1985;5:918\u2013927.","journal-title":"J Am Coll Cardiol"},{"key":"2_CR44","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/adc.2007.120493","volume":"93","author":"S.G. Haworth","year":"2008","unstructured":"Haworth SG. The management of pulmonary hypertension in children. Arch Dis Child 2008;93:620\u2013625.","journal-title":"Arch Dis Child"},{"key":"2_CR45","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/bja\/aem059","volume":"98","author":"C.J. Taylor","year":"2007","unstructured":"Taylor CJ, Derrick G, McEwan A, Haworth SG, Sury MR. Risk of cardiac catheterization under anaesthesia in children with pulmonary hypertension. Br J Anaesth 2007;98:657\u2013661.","journal-title":"Br J Anaesth"},{"key":"2_CR46","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1213\/01.ane.0000255732.16057.1c","volume":"104","author":"M.J. Carmosino","year":"2007","unstructured":"Carmosino MJ, Friesen RH, Doran A, Ivy DD. Perioperative complications in children with pulmonary hypertension undergoing noncardiac surgery or cardiac catheterization. Anesth Analg 2007;104:521\u2013527.","journal-title":"Anesth Analg"},{"key":"2_CR47","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/hrt.79.2.169","volume":"79","author":"M.I. Turanlahti","year":"1998","unstructured":"Turanlahti MI, Laitinen PO, Sarna SJ, Pesonen E. Nitric oxide, oxygen, and prostacyclin in children with pulmonary hypertension. Heart 1998;79:169\u2013174.","journal-title":"Heart"},{"key":"2_CR48","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/S0735-1097(00)00994-3","volume":"36","author":"R.A. Krasuski","year":"2000","unstructured":"Krasuski RA, Warner JJ, Wang A, Harrison JK, Tapson VF, Bashore TM. Inhaled nitric oxide selectively dilates pulmonary vasculature in adult patients with pulmonary hypertension, irrespective of etiology. J Am Coll Cardiol 2000;36:2204\u20132211.","journal-title":"J Am Coll Cardiol"},{"key":"2_CR49","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s002469900463","volume":"20","author":"T. Yasuda","year":"1999","unstructured":"Yasuda T, Tauchi N, Baba R, Nishibata K, Hatano T, Nakamura S, et al. Inhalation of low-dose nitric oxide to evaluate pulmonary vascular reactivity in children with congenital heart disease. Pediatr Cardiol 1999;20:278\u2013282.","journal-title":"Pediatr Cardiol"},{"key":"2_CR50","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00246-004-0767-5","volume":"26","author":"B.C. Cannon","year":"2005","unstructured":"Cannon BC, Feltes TF, Fraley JK, Grifka RG, Riddle EM, Kovalchin JP. Nitric oxide in the evaluation of congenital heart disease with pulmonary hypertension: factors related to nitric oxide response. Pediatr Cardiol 2005;26:565\u2013569.","journal-title":"Pediatr Cardiol"},{"key":"2_CR51","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0002-9149(97)89353-8","volume":"77","author":"M. Berner","year":"1996","unstructured":"Berner M, Beghetti M, Spahr-Schopfer I, Oberhansli I, Friedli B. Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease. Am J Cardiol 1996;77:532\u2013535.","journal-title":"Am J Cardiol"},{"key":"2_CR52","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.ehj.2004.07.005","volume":"25","author":"M.C. Post","year":"2004","unstructured":"Post MC, Janssens S, Van de Werf F, Budts W. Responsiveness to inhaled nitric oxide is a predictor for mid-term survival in adult patients with congenital heart defects and pulmonary arterial hypertension. Eur Heart J 2004;25:1651\u20131656.","journal-title":"Eur Heart J"},{"key":"2_CR53","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ccd.1810100308","volume":"10","author":"J. Fujiyama","year":"1984","unstructured":"Fujiyama J, Yoshida Y, Ogata H, Kato T, Kuteken O, Oyama K. Pulmonary wedge angiography for the evaluation of the pulmonary vascular bed in congenital heart disease. Cathet Cardiovasc Diagn 1984;10:237\u2013246.","journal-title":"Cathet Cardiovasc Diagn"},{"key":"2_CR54","first-page":"117","volume":"10","author":"A. Grubstein","year":"2008","unstructured":"Grubstein A, Benjaminov O, Dayan DB, Shitrit D, Cohen M, Kramer MR. Computed tomography angiography in pulmonary hypertension. Isr Med Assoc J 2008;10:117\u2013120.","journal-title":"Isr Med Assoc J"},{"key":"2_CR55","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1161\/CIRCULATIONAHA.104.509869","volume":"112","author":"R. Sheehan","year":"2005","unstructured":"Sheehan R, Perloff JK, Fishbein MC, Gjertson D, Aberle DR. Pulmonary neovascularity: a distinctive radiographic finding in Eisenmenger syndrome. Circulation 2005;112:2778\u20132785.","journal-title":"Circulation"},{"key":"2_CR56","doi-asserted-by":"crossref","first-page":"142","DOI":"10.21693\/1933-088X-6.3.142","volume":"6","author":"R.J. Barst","year":"2007","unstructured":"Barst RJ, Fineman JR, Gatzoulis MA, Krasuski RA. Pulmonary hypertension roundtable: pulmonary arterial hypertension in adults with congenital heart disease. Adv Pulmonary Hypertens 2007;6:142\u2013148.","journal-title":"Adv Pulmonary Hypertens"},{"key":"2_CR57","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMra040291","volume":"351","author":"M. Humbert","year":"2004","unstructured":"Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004;351:1425\u20131436.","journal-title":"N Engl J Med"},{"key":"2_CR58","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1056\/NEJM199801293380501","volume":"338","author":"V.V. McLaughlin","year":"1998","unstructured":"McLaughlin VV, Genthner DE, Panella MM, Rich S. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med 1998;338:273\u2013277.","journal-title":"N Engl J Med"},{"key":"2_CR59","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/hrt.2006.096412","volume":"93","author":"A.E. Lammers","year":"2007","unstructured":"Lammers AE, Hislop AA, Flynn Y, Haworth SG. Epoprostenol treatment in children with severe pulmonary hypertension. Heart 2007;93:739\u2013743.","journal-title":"Heart"},{"key":"2_CR60","volume-title":"Pediatric dosage handbook: including neonatal dosing, drug administration, & extemporaneous preparations","author":"C.K. Taketomo","year":"2006","unstructured":"Taketomo CK, Hodding JH, Kraus DM. Pediatric dosage handbook: including neonatal dosing, drug administration, & extemporaneous preparations, 13th ed. Ohio: Lexi-Comp Inc., 2006.","edition":"13th ed"},{"key":"2_CR61","first-page":"503","volume-title":"Current pediatric therapy","author":"C.L. Dent","year":"2006","unstructured":"Dent CL. Pulmonary hypertension in children. In: Burg FD, Ingelfinger JR, Polin RA, Gershon AA, eds. Current pediatric therapy, 18th ed. Philadelphia: Elsevier Inc., 2006: 503\u2013510.","edition":"18th ed"},{"key":"2_CR62","doi-asserted-by":"crossref","first-page":"56S","DOI":"10.1016\/j.jacc.2004.02.036","volume":"43","author":"D.B. Badesch","year":"2004","unstructured":"Badesch DB, McLaughlin VV, Delcroix M, Vizza CD, Olschewski H, Sitbon O, et al. Prostanoid therapy for pulmonary arterial hypertension. J Am Coll Cardiol 2004;43: 56S\u201361S.","journal-title":"J Am Coll Cardiol"},{"key":"2_CR63","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1378\/chest.129.3.683","volume":"129","author":"V.F. Tapson","year":"2006","unstructured":"Tapson VF, Gomberg-Maitland M, McLaughlin VV, Benza RL, Widlitz AC, Krichman A, et al. Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trial. Chest 2006;129:683\u2013688.","journal-title":"Chest"},{"key":"2_CR64","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1164\/rccm.200505-766OC","volume":"172","author":"M. Gomberg-Maitland","year":"2005","unstructured":"Gomberg-Maitland M, Tapson VF, Benza RL, McLaughlin VV, Krichman A, Widlitz AC, et al. Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension. Am J Respir Crit Care Med 2005;172:1586\u20131589.","journal-title":"Am J Respir Crit Care Med"},{"key":"2_CR65","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ccd.21389","volume":"71","author":"M.H. Park","year":"2008","unstructured":"Park MH. Advances in diagnosis and treatment in patients with pulmonary arterial hypertension. Catheter Cardiovasc Interv 2008;71:205\u2013213.","journal-title":"Catheter Cardiovasc Interv"},{"key":"2_CR66","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1056\/NEJM200006223422503","volume":"342","author":"M.M. Hoeper","year":"2000","unstructured":"Hoeper MM, Schwarze M, Ehlerding S, Adler-Schuermeyer A, Spiekerkoetter E, Niedermeyer J, et al. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. N Engl J Med 2000;342:1866\u20131870.","journal-title":"N Engl J Med"},{"key":"2_CR67","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2007.09.031","volume":"51","author":"D.D. Ivy","year":"2008","unstructured":"Ivy DD, Doran AK, Smith KJ, Mallory GB Jr, Beghetti M, Barst RJ, et al. Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension. J Am Coll Cardiol 2008;51:161\u2013169.","journal-title":"J Am Coll Cardiol"},{"key":"2_CR68","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00246-005-0925-4","volume":"26","author":"A. Limsuwan","year":"2005","unstructured":"Limsuwan A, Pienvichit P, Khowsathit P. Beraprost therapy in children with pulmonary hypertension secondary to congenital heart disease. Pediatr Cardiol 2005;26:787\u2013791.","journal-title":"Pediatr Cardiol"},{"key":"2_CR69","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0735-1097(02)01786-2","volume":"39","author":"N. Gali\u00e8","year":"2002","unstructured":"Gali\u00e8 N, Humbert M, Vachi\u00e9ry JL, Vizza CD, Kneussl M, Manes A, et al. Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol 2002;39:1496\u20131502.","journal-title":"J Am Coll Cardiol"},{"key":"2_CR70","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0735-1097(03)00463-7","volume":"41","author":"R.J. Barst","year":"2003","unstructured":"Barst RJ, McGoon M, McLaughlin V, Tapson V, Oudiz R, Shapiro S, et al. Beraprost therapy for pulmonary arterial hypertension. J Am Coll Cardiol 2003;41:2119\u20132125.","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl8","key":"2_CR71","first-page":"S60","volume":"88","author":"K. Durongpisitkul","year":"2005","unstructured":"Durongpisitkul K, Jakrapanichakul D, Laohaprasitiporn D, Soongswang J, Chanthong P, Nana A. Combination therapy of prostacyclin for pulmonary hypertension in congenital heart disease. J Med Assoc Thai 2005;88(Suppl 8):S60\u201365.","journal-title":"J Med Assoc Thai"},{"key":"2_CR72","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s001090050363","volume":"77","author":"S. Roux","year":"1999","unstructured":"Roux S, Breu V, Ertel SI, Clozel M. Endothelin antagonism with bosentan: a review of potential applications. J Mol Med 1999;77:364\u2013376.","journal-title":"J Mol Med"},{"key":"2_CR73","doi-asserted-by":"crossref","first-page":"62S","DOI":"10.1016\/j.jacc.2004.02.042","volume":"43","author":"R.N. Channick","year":"2004","unstructured":"Channick RN, Sitbon O, Barst RJ, Manes A, Rubin LJ. Endothelin receptor antagonists in pulmonary arterial hypertension. J Am Coll Cardiol 2004;43:62S\u201367S.","journal-title":"J Am Coll Cardiol"},{"key":"2_CR74","first-page":"2280","volume":"84","author":"M. Yoshibayashi","year":"1991","unstructured":"Yoshibayashi M, Nishioka K, Nakao K, Saito Y, Matsumura M, Ueda T, et al. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation. Circulation 1991;84:2280\u20132285.","journal-title":"Evidence for increased production of endothelin in pulmonary circulation. Circulation"},{"key":"2_CR75","first-page":"653","volume":"56","author":"I.H. Ozerol","year":"2004","unstructured":"Ozerol IH, Pac FA, Ozerol E, Ege E, Yologlu S, Temel I, et al. Plasma endothelin-1, homocysteine and serum nitric oxide values in patients with left-to-right shunt. Indian Heart J 2004;56:653\u2013657.","journal-title":"Indian Heart J"},{"key":"2_CR76","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","volume":"346","author":"L.J. Rubin","year":"2002","unstructured":"Rubin LJ, Badesch DB, Barst RJ, Gali\u00e8 N, Black CM, Keogh A, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002;346:896\u2013903.","journal-title":"N Engl J Med"},{"key":"2_CR77","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/hrt.2005.072314","volume":"92","author":"S. Maiya","year":"2006","unstructured":"Maiya S, Hislop AA, Flynn Y, Haworth SG. Response to bosentan in children with pulmonary hypertension. Heart 2006; 92:664\u2013670.","journal-title":"Heart"},{"key":"2_CR78","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s00392-005-0266-6","volume":"94","author":"N. Gilbert","year":"2005","unstructured":"Gilbert N, Luther YC, Miera O, Nagdyman N, Ewert P, Berger F, et al. Initial experience with bosentan (Tracleer) as treatment for pulmonary arterial hypertension (PAH) due to congenital heart disease in infants and young children. Z Kardiol 2005;94: 570\u2013574.","journal-title":"Z Kardiol"},{"key":"2_CR79","first-page":"491","volume":"58","author":"S. Rugolotto","year":"2006","unstructured":"Rugolotto S, Errico G, Beghini R, Ilic S, Richelli C, Padovani EM. Weaning of epoprostenol in a small infant receiving concomitant bosentan for severe pulmonary arterial hypertension secondary to bronchopulmonary dysplasia. Minerva Pediatr 2006;58:491\u2013494.","journal-title":"Minerva Pediatr"},{"key":"2_CR80","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s00246-007-0037-4","volume":"28","author":"J.K. Votava-Smith","year":"2007","unstructured":"Votava-Smith JK, Perens GS, Alejos JC. Bosentan for increased pulmonary vascular resistance in a patient with single ventricle physiology and a bidirectional Glenn shunt. Pediatr Cardiol 2007;28:314\u2013316.","journal-title":"Pediatr Cardiol"},{"key":"2_CR81","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijcard.2004.08.025","volume":"98","author":"M.A. Gatzoulis","year":"2005","unstructured":"Gatzoulis MA, Rogers P, Li W, Harries C, Cramer D, Ward S, et al. Safety and tolerability of bosentan in adults with Eisenmenger physiology. Int J Cardiol 2005;98:147\u2013151.","journal-title":"Int J Cardiol"},{"key":"2_CR82","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ahj.2005.07.005","volume":"150","author":"I. Schulze-Neick","year":"2005","unstructured":"Schulze-Neick I, Gilbert N, Ewert R, Witt C, Gruenig E, Enke B, et al. Adult patients with congenital heart disease and pulmonary arterial hypertension: first open prospective multicenter study of bosentan therapy. Am Heart J 2005;150:716.","journal-title":"Am Heart J"},{"key":"2_CR83","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1378\/chest.129.4.1009","volume":"129","author":"R.L. Benza","year":"2006","unstructured":"Benza RL, Rayburn BK, Tallaj JA, Coffey CS, Pinderski LJ, Pamoukian SV, et al. Efficacy of bosentan in a small cohort of adult patients with pulmonary arterial hypertension related to congenital heart disease. Chest 2006;129:1009\u20131015.","journal-title":"Chest"},{"issue":"Suppl3","key":"2_CR84","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2362.2006.01685.x","volume":"36","author":"O. Sitbon","year":"2006","unstructured":"Sitbon O, Beghetti M, Petit J, Iserin L, Humbert M, Gressin V, et al. Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects. Eur J Clin Invest 2006;36(Suppl 3):25\u201331.","journal-title":"Eur J Clin Invest"},{"key":"2_CR85","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1155\/2006\/746176","volume":"13","author":"R. Ibrahim","year":"2006","unstructured":"Ibrahim R, Granton JT, Mehta S. An open-label, multicentre pilot study of bosentan in pulmonary arterial hypertension related to congenital heart disease. Can Respir J 2006;13: 415\u2013420.","journal-title":"Can Respir J"},{"key":"2_CR86","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1136\/hrt.2006.097360","volume":"93","author":"M. D\u2019Alto","year":"2007","unstructured":"D\u2019Alto M, Vizza CD, Romeo E, Badagliacca R, Santoro G, Poscia R, et al. Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): safety, tolerability, clinical, and haemodynamic effect. Heart 2007;93:621\u2013625.","journal-title":"Heart"},{"key":"2_CR87","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/hrt.2006.089185","volume":"93","author":"G.P. Diller","year":"2007","unstructured":"Diller GP, Dimopoulos K, Kaya MG, Harries C, Uebing A, Li W, et al. Long-term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease. Heart 2007;93:974\u2013976.","journal-title":"Heart"},{"key":"2_CR88","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1017\/S1047951106000114","volume":"16","author":"E. Kotlyar","year":"2006","unstructured":"Kotlyar E, Sy R, Keogh AM, Kermeen F, Macdonald PS, Hayward CS, et al. Bosentan for the treatment of pulmonary arterial hypertension associated with congenital cardiac disease. Cardiol Young 2006;16:268\u2013274.","journal-title":"Cardiol Young"},{"key":"2_CR89","first-page":"196","volume":"91","author":"K. Durongpisitkul","year":"2008","unstructured":"Durongpisitkul K, Jakrapanichakul D, Sompradikul S. A retrospective study of bosentan in pulmonary arterial hypertension associated with congenital heart disease. J Med Assoc Thai 2008;91:196\u2013202.","journal-title":"J Med Assoc Thai"},{"key":"2_CR90","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ahj.2007.06.003","volume":"154","author":"R.L. Loon van","year":"2007","unstructured":"van Loon RL, Hoendermis ES, Duffels MG, Vonk-Noordegraaf A, Mulder BJ, Hillege HL, et al. Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist? Am Heart J 2007;154:776\u2013782.","journal-title":"Am Heart J"},{"key":"2_CR91","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/hrt.2006.100388","volume":"93","author":"S.C. Apostolopoulou","year":"2007","unstructured":"Apostolopoulou SC, Manginas A, Cokkinos DV, Rammos S. Long-term oral bosentan treatment in patients with pulmonary arterial hypertension related to congenital heart disease: a 2-year study. Heart 2007;93:350\u2013354.","journal-title":"Heart"},{"key":"2_CR92","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.106.630715","volume":"114","author":"N. Gali\u00e8","year":"2006","unstructured":"Gali\u00e8 N, Beghetti M, Gatzoulis MA, Granton J, Berger RM, Lauer A, et al. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebocontrolled study. Circulation 2006;114:48\u201354.","journal-title":"Circulation"},{"key":"2_CR93","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(08)60919-8","volume":"371","author":"N. Gali\u00e8","year":"2008","unstructured":"Gali\u00e8 N, Rubin LJ, Hoeper MM, Jansa P, Al-Hiti H, Meyer GM, et al. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY) study: a doubleblind, randomised, controlled trial. Lancet 2008;371:2093\u20132100.","journal-title":"Lancet"},{"key":"2_CR94","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0009-9236(03)00005-5","volume":"73","author":"R.J. Barst","year":"2003","unstructured":"Barst RJ, Ivy D, Dingemanse J, Widlitz A, Schmitt K, Doran A, et al. Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension. Clin Pharmacol Ther 2003;73:372\u2013382.","journal-title":"Clin Pharmacol Ther"},{"key":"2_CR95","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1164\/rccm.200307-957OC","volume":"169","author":"R.J. Barst","year":"2004","unstructured":"Barst RJ, Langleben D, Frost A, Horn EM, Oudiz R, Shapiro S, et al. Sitaxsentan therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med 2004;169:441\u2013447.","journal-title":"Am J Respir Crit Care Med"},{"key":"2_CR96","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.jacc.2006.01.057","volume":"47","author":"R.J. Barst","year":"2006","unstructured":"Barst RJ, Langleben D, Badesch D, Frost A, Lawrence EC, Shapiro S, et al. Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan. J Am Coll Cardiol 2006;47:2049\u20132056.","journal-title":"J Am Coll Cardiol"},{"key":"2_CR97","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1378\/chest.126.4.1377","volume":"126","author":"D. Langleben","year":"2004","unstructured":"Langleben D, Hirsch AM, Shalit E, Lesenko L, Barst RJ. Sustained symptomatic, functional, and hemodynamic benefit with the selective endothelin-A receptor antagonist, sitaxsentan, in patients with pulmonary arterial hypertension: a 1-year follow-up study. Chest 2004;126:1377\u20131381.","journal-title":"Chest"},{"key":"2_CR98","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.healun.2006.10.019","volume":"26","author":"R.L. Benza","year":"2007","unstructured":"Benza RL, Mehta S, Keogh A, Lawrence EC, Oudiz RJ, Barst RJ. Sitaxsentan treatment for patients with pulmonary arterial hypertension discontinuing bosentan. J Heart Lung Transplant 2007;26:63\u201369.","journal-title":"J Heart Lung Transplant"},{"key":"2_CR99","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jacc.2005.04.050","volume":"46","author":"N. Gali\u00e8","year":"2005","unstructured":"Gali\u00e8 N, Badesch D, Oudiz R, Simonneau G, McGoon MD, Keogh AM, et al. Ambrisentan therapy for pulmonary arterial hypertension. J Am Coll Cardiol 2005;46:529\u2013535.","journal-title":"J Am Coll Cardiol"},{"key":"2_CR100","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","volume":"353","author":"N. Gali\u00e8","year":"2005","unstructured":"Gali\u00e8 N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005;353:2148\u20132157.","journal-title":"N Engl J Med"},{"key":"2_CR101","first-page":"404","volume":"54","author":"S.S. Kothari","year":"2002","unstructured":"Kothari SS, Duggal B. Chronic oral sildenafil therapy in severe pulmonary artery hypertension. Indian Heart J 2002;54: 404\u2013409.","journal-title":"Indian Heart J"},{"key":"2_CR102","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1157\/13101640","volume":"60","author":"I. Raposo-Sonnenfeld","year":"2007","unstructured":"Raposo-Sonnenfeld I, Otero-Gonz\u00e1lez I, Blanco-Aparicio M, Ferrer-Barba \u00c1, Medrano-L\u00f3pez C. Treatment with sildenafil, bosentan, or both in children and young people with idiopathic pulmonary arterial hypertension and Eisenmenger\u2019s syndrome. Rev Esp Cardiol 2007;60:366\u2013372.","journal-title":"Rev Esp Cardiol"},{"key":"2_CR103","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/eurheartj\/ehn215","volume":"29","author":"A. Giardini","year":"2008","unstructured":"Giardini A, Balducci A, Specchia S, Gargiulo G, Bonvicini M, Picchio FM. Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients. Eur Heart J 2008;29:1681\u20131687.","journal-title":"Eur Heart J"},{"key":"2_CR104","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/021849230701500207","volume":"15","author":"F. Peiravian","year":"2007","unstructured":"Peiravian F, Amirghofran AA, Borzouee M, Ajami GH, Sabri MR, Kolaee S. Oral sildenafil to control pulmonary hypertension after congenital heart surgery. Asian Cardiovasc Thorac Ann 2007;15:113\u2013117.","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"2_CR105","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/j.jvca.2006.02.010","volume":"21","author":"S.G. Raja","year":"2007","unstructured":"Raja SG, Danton MD, MacArthur KJ, Pollock JC. Effects of escalating doses of sildenafil on hemodynamics and gas exchange in children with pulmonary hypertension and congenital cardiac defects. J Cardiothorac Vasc Anesth 2007;21: 203\u2013207.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2_CR106","first-page":"453","volume":"108","author":"L. Kovacikova","year":"2007","unstructured":"Kovacikova L, Zahorec M, Nosal M. Sildenafil as a pulmonary vasodilator after repair of congenital heart disease. Bratisl Lek Listy 2007;108:453\u2013454.","journal-title":"Bratisl Lek Listy"},{"key":"2_CR107","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1164\/rccm.200605-694OC","volume":"174","author":"P. Namachivayam","year":"2006","unstructured":"Namachivayam P, Theilen U, Butt WW, Cooper SM, Penny DJ, Shekerdemian LS. Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children. Am J Respir Crit Care Med 2006;174:1042\u20131047.","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl1","key":"2_CR108","first-page":"II167","volume":"108","author":"I. Schulze-Neick","year":"2003","unstructured":"Schulze-Neick I, Hartenstein P, Li J, Stiller B, Nagdyman N, H\u00fcbler M, et al. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease. Circulation 2003;108(Suppl 1):II167\u2013173.","journal-title":"Circulation"},{"key":"2_CR109","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1017\/S1047951105002155","volume":"16","author":"A.E. Lammers","year":"2006","unstructured":"Lammers AE, Haworth SG, Pierce CM. Intravenous sildenafil as an effective treatment of pulmonary hypertensive crises during acute intestinal malabsorption. Cardiol Young 2006;16: 84\u201386.","journal-title":"Cardiol Young"},{"key":"2_CR110","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijcard.2004.09.002","volume":"100","author":"A.A. Karatza","year":"2005","unstructured":"Karatza AA, Bush A, Magee AG. Safety and efficacy of Sildenafil therapy in children with pulmonary hypertension. Int J Cardiol 2005;100:267\u2013273.","journal-title":"Int J Cardiol"},{"key":"2_CR111","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000097125","volume":"91","author":"S. Noori","year":"2007","unstructured":"Noori S, Friedlich P, Wong P, Garingo A, Seri I. Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension. Neonatology 2007;91:92\u2013100.","journal-title":"Neonatology"},{"key":"2_CR112","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1056\/NEJMsa063904","volume":"355","author":"F. Murad","year":"2006","unstructured":"Murad F. Nitric oxide and cyclic GMP in cell signaling and drug development. N Engl J Med 2006;355:2003\u20132011.","journal-title":"N Engl J Med"},{"key":"2_CR113","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0735-1097(83)80344-1","volume":"2","author":"J.D. Waldman","year":"1983","unstructured":"Waldman JD, Lamberti JJ, Mathewson JW, Kirkpatrick SE, Turner SW, George L, et al. Congenital heart disease and pulmonary artery hypertension. I. Pulmonary vasoreactivity to 15% oxygen before and after surgery. J Am Coll Cardiol 1983;2:1158\u20131164.","journal-title":"J Am Coll Cardiol"},{"key":"2_CR114","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1442-200x.2000.01219.x","volume":"42","author":"F. Kotake","year":"2000","unstructured":"Kotake F, Kobayashi J, Sonoda M, Komoda T. Nitric oxiderelated compounds in patients with congenital heart defects and pulmonary hypertension. Pediatr Int 2000;42:249\u2013254.","journal-title":"Pediatr Int"},{"key":"2_CR115","first-page":"2053","volume":"90","author":"P. Kiettisanpipop","year":"2007","unstructured":"Kiettisanpipop P, Lertsapcharorn P, Chotivittayatarakorn P, Poovorawan Y. Plasma levels of nitric oxide in children with congenital heart disease and increased pulmonary blood flow. J Med Assoc Thai 2007;90:2053\u20132057.","journal-title":"J Med Assoc Thai"},{"key":"2_CR116","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0022-5223(94)70390-6","volume":"107","author":"D. Journois","year":"1994","unstructured":"Journois D, Pouard P, Mauriat P, Malh\u00e8re T, Vouh\u00e9 P, Safran D. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects. J Thorac Cardiovas Surg 1994;107:1129\u20131135.","journal-title":"J Thorac Cardiovas Surg"},{"key":"2_CR117","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/hrt.73.1.65","volume":"73","author":"M. Beghetti","year":"1995","unstructured":"Beghetti M, Habre W, Friedli B, Berner M. Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients. Br Heart J 1995;73:65\u201368.","journal-title":"Br Heart J"},{"key":"2_CR118","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/0003-4975(95)00408-D","volume":"60","author":"A.P. Goldman","year":"1995","unstructured":"Goldman AP, Delius RE, Deanfield JE, Macrae DJ. Nitric oxide is superior to prostacyclin for pulmonary hypertension after cardiac operations. Ann Thorac Surg 1995;60:300\u2013305.","journal-title":"Ann Thorac Surg"},{"key":"2_CR119","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1525-1594.1997.tb00690.x","volume":"21","author":"H. Shimpo","year":"1997","unstructured":"Shimpo H, Mitani Y, Tanaka J, Mizumoto T, Onoda K, Tani K, et al. Inhaled low-dose nitric oxide for postoperative care in patients with congenital heart defects. Artif Organs 1997; 21:10\u201313.","journal-title":"Artif Organs"},{"key":"2_CR120","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1213\/00000539-199807000-00011","volume":"87","author":"I.A. Russell","year":"1998","unstructured":"Russell IA, Zwass MS, Fineman JR, Balea M, Rouine-Rapp K, Brook M, et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesth Analg 1998;87:46\u201351.","journal-title":"Anesth Analg"},{"key":"2_CR121","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF02845523","volume":"66","author":"K.S. Murthy","year":"1999","unstructured":"Murthy KS, Rao SG, Prakash KS, Robert C, Dhinakar S, Cherian KM. Role of inhaled nitric oxide as a selective pulmonary vasodilator in pediatric cardiac surgical practice. Indian J Pediatr 1999;66:357\u2013361.","journal-title":"Indian J Pediatr"},{"key":"2_CR122","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/14017430050142161","volume":"34","author":"S. G\u00f6thberg","year":"2000","unstructured":"G\u00f6thberg S, Edberg KE. Inhaled nitric oxide to newborns and infants after congenital heart surgery on cardiopulmonary bypass. A dose-response study. Scan Cardiovasc J 2000;34: 154\u2013158.","journal-title":"A dose-response study. Scan Cardiovasc J"},{"key":"2_CR123","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0003-4975(00)01312-6","volume":"69","author":"R.W. Day","year":"2000","unstructured":"Day RW, Hawkins JA, McGough EC, Creze\u00e9 KL, Orsmond GS. Randomized controlled study of inhaled nitric oxide after operation for congenital heart disease. Ann Thorac Surg 2000;69:1907\u20131912.","journal-title":"Ann Thorac Surg"},{"key":"2_CR124","first-page":"48","volume":"53","author":"R. Sharma","year":"2001","unstructured":"Sharma R, Raizada N, Choudhary SK, Bhan A, Kumar P, Juneja R, et al. Does inhaled nitric oxide improve survival in operated congenital disease with severe pulmonary hypertension? Indian Heart J 2001;53:48\u201355.","journal-title":"Indian Heart J"},{"key":"2_CR125","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1159\/000086258","volume":"72","author":"G. P\u00e9rez-Pe\u00f1ate","year":"2005","unstructured":"P\u00e9rez-Pe\u00f1ate G, Cabrera Navarro P, Ponce Gonz\u00e1lez M, G\u00f3rriz G\u00f3mez E, Pulido Duque J, Garc\u00eda Quintana A, et al. Long-term inhaled nitric oxide plus dipyridamole for pulmonary arterial hypertension. Respiration 2005;72:419\u2013422.","journal-title":"Respiration"},{"key":"2_CR126","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/bja\/ael112","volume":"97","author":"P. Goyal","year":"2006","unstructured":"Goyal P, Kiran U, Chauhan S, Juneja R, Choudhary M. Efficacy of nitroglycerin inhalation in reducing pulmonary arterial hypertension in children with congenital heart disease. Br J Anaesth 2006;97:208\u2013214.","journal-title":"Br J Anaesth"},{"key":"2_CR127","first-page":"74","volume":"95","author":"H.A. Omar","year":"1999","unstructured":"Omar HA, Gong F, Sun MY, Einzig S. Nebulized nitroglycerin in children with pulmonary hypertension secondary to congenital heart disease. W V Med J 1999;95:74\u201375.","journal-title":"W V Med J"},{"key":"2_CR128","first-page":"368","volume":"51","author":"D.J. Levine","year":"2006","unstructured":"Levine DJ. Diagnosis and management of pulmonary arterial hypertension: implications for respiratory care. Respir Care 2006;51:368\u2013381.","journal-title":"Respir Care"},{"key":"2_CR129","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jacc.2005.01.066","volume":"46","author":"E.B. Rosenzweig","year":"2005","unstructured":"Rosenzweig EB, Ivy DD, Widlitz A, Doran A, Claussen LR, Yung D, et al. Effects of long-term bosentan in children with pulmonary arterial hypertension. J Am Coll Cardiol 2005;46:697\u2013704.","journal-title":"J Am Coll Cardiol"},{"key":"2_CR130","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0735-1097(03)00555-2","volume":"42","author":"H.A. Ghofrani","year":"2003","unstructured":"Ghofrani HA, Rose F, Schermuly RT, Olschewski H, Wiedemann R, Kreckel A, et al. Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension. J Am Coll Cardiol 2003;42:158\u2013164.","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl3","key":"2_CR131","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2362.2006.01692.x","volume":"36","author":"K. Lunze","year":"2006","unstructured":"Lunze K, Gilbert N, Mebus S, Miera O, Fehske W, Uhlemann F, et al. First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension. Eur J Clin Invest 2006;36(Suppl 3):32\u201338.","journal-title":"Eur J Clin Invest"},{"key":"2_CR132","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ccl.2004.04.004","volume":"22","author":"R. Channick","year":"2004","unstructured":"Channick R, Williamson TL. Diagnosis and treatment of pulmonary arterial hypertension. Cardiol Clin 2004;22:441\u2013452.","journal-title":"Cardiol Clin"},{"key":"2_CR133","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1183\/09031936.06.00095705","volume":"27","author":"I.M. Robbins","year":"2006","unstructured":"Robbins IM, Kawut SM, Yung D, Reilly MP, Lloyd W, Cunningham G, et al. A study of aspirin and clopidogrel in idiopathic pulmonary arterial hypertension. Eur Respir J 2006; 27:578\u2013584.","journal-title":"Eur Respir J"},{"key":"2_CR134","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1067\/mpd.2003.mpd0311","volume":"142","author":"F.E. Barr","year":"2003","unstructured":"Barr FE, Beverley H, VanHook K, Cermak E, Christian K, Drinkwater D, et al. Effect of cardiopulmonary bypass on urea cycle intermediates and nitric oxide levels after congenital heart surgery. J Pediatr 2003;142:26\u201330.","journal-title":"J Pediatr"},{"key":"2_CR135","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jtcvs.2006.02.012","volume":"132","author":"H.A. Smith","year":"2006","unstructured":"Smith HA, Canter JA, Christian KG, Drinkwater DC, Scholl FG, Christman BW, et al. Nitric oxide precursors and congenital heart surgery: a randomized controlled trial of oral citrulline. J Thorac Cardiovasc Surg 2006;132:58\u201365.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2_CR136","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jtcvs.2007.02.043","volume":"134","author":"F.E. Barr","year":"2007","unstructured":"Barr FE, Tirona RG, Taylor MB, Rice G, Arnold J, Cunningham G, et al. Pharmacokinetics and safety of intravenously administered citrulline in children undergoing congenital heart surgery: potential therapy for postoperative pulmonary hypertension. J Thorac Cardiovasc Surg 2007;134:319\u2013326.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2_CR137","doi-asserted-by":"crossref","first-page":"73S","DOI":"10.1016\/j.jacc.2004.02.039","volume":"43","author":"W. Klepetko","year":"2004","unstructured":"Klepetko W, Mayer E, Sandoval J, Trulock EP, Vachiery JL, Dartevelle P, et al. Interventional and surgical modalities of treatment for pulmonary arterial hypertension. J Am Coll Cardiol 2004;43:73S\u201380S.","journal-title":"J Am Coll Cardiol"},{"key":"2_CR138","doi-asserted-by":"crossref","first-page":"136","DOI":"10.21693\/1933-088X-6.3.136","volume":"6","author":"M.J. Landzberg","year":"2007","unstructured":"Landzberg MJ. Emerging therapy of congenital heart disease associated with pulmonary hypertension. Adv Pulmonary Hypertens 2007;6:136\u2013141.","journal-title":"Adv Pulmonary Hypertens"},{"key":"2_CR139","first-page":"21","volume":"18","author":"I.U. Khan","year":"2006","unstructured":"Khan IU, Ahmed I, Mufti WA, Rashid A, Khan AA, Ahmed SA, et al. Ventricular septal defect in infants and children with increased pulmonary vascular resistance and pulmonary hypertension\u2014surgical management: leaving an atrial level communication. J Ayub Med Coll Abbottabad 2006;18:21\u201325.","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"2_CR140","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1378\/chest.36.6.631","volume":"36","author":"R. Larios","year":"1959","unstructured":"Larios R, Fitch EA, Blanco G, Bailey CP. The use of an artificial foraminal valve prosthesis in the closure of interatrial and interventricular septal defect. Dis Chest 1959;36:631\u2013641.","journal-title":"Dis Chest"},{"key":"2_CR141","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0003-4975(98)00956-4","volume":"66","author":"W.M. Novick","year":"1998","unstructured":"Novick WM, Gurbuz AT, Watson DC, Lazorishinets VV, Perepeka AN, Malcic I, et al. Double patch closure of ventricular septal defect with increased pulmonary vascular resistance. Ann Thorac Surg 1998;66:1533\u20131538.","journal-title":"Ann Thorac Surg"},{"key":"2_CR142","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.athoracsur.2004.06.107","volume":"79","author":"W.M. Novick","year":"2005","unstructured":"Novick WM, Sandoval N, Lazorhysynets VV, Castillo V, Baskevitch A, Mo X, et al. Flap valve double patch closure of ventricular septal defects in children with increased pulmonary vascular resistance. Ann Thorac Surg 2005;79:21\u201328.","journal-title":"Ann Thorac Surg"},{"key":"2_CR143","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/021849230601400612","volume":"14","author":"A. Afrasiabi","year":"2006","unstructured":"Afrasiabi A, Samadi M, Montazergaem H. Valved patch for ventricular septal defect with pulmonary arterial hypertension. Asian Cardiovasc Thorac Ann 2006;14:501\u2013504.","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"2_CR144","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1016\/j.athoracsur.2007.02.006","volume":"83","author":"B. Zhang","year":"2007","unstructured":"Zhang B, Wu S, Liang J, Zhang G, Jiang G, Zhou M, et al. Unidirectional monovalve homologous aortic patch for repair of ventricular septal defect with pulmonary hypertension. Ann Thorac Surg 2007;83:2176\u20132181.","journal-title":"Ann Thorac Surg"},{"key":"2_CR145","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1053-2498(01)00420-X","volume":"21","author":"T.K. Waddell","year":"2002","unstructured":"Waddell TK, Bennett L, Kennedy R, Todd TR, Keshavjee SH. Heart-lung or lung transplantation for Eisenmenger syndrome. J Heart Lung Transplant 2002;21:731\u2013737.","journal-title":"J Heart Lung Transplant"},{"key":"2_CR146","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jtcvs.2004.07.058","volume":"129","author":"C.K. Choong","year":"2005","unstructured":"Choong CK, Sweet SC, Guthrie TJ, Mendeloff EN, Haddad FJ, Schuler P, et al. Repair of congenital heart lesions combined with lung transplantation for the treatment of severe pulmonary hypertension: a 13-year experience. J Thorac Cardiovasc Surg 2005;129:661\u2013669.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2_CR147","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1093\/eurheartj\/ehl116","volume":"27","author":"G.P. Diller","year":"2006","unstructured":"Diller GP, Dimopoulos K, Broberg CS, Kaya MG, Naghotra US, Uebing A, et al. Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study. Eur Heart J 2006;27:1737\u20131742.","journal-title":"Eur Heart J"},{"key":"2_CR148","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.prrv.2006.03.004","volume":"7","author":"R. Radley-Smith","year":"2006","unstructured":"Radley-Smith R, Aurora P. Transplantation as a treatment for end-stage pulmonary hypertension in childhood. Paediatr Respir Rev 2006;7:117\u2013122.","journal-title":"Paediatr Respir Rev"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-010-0002-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12519-010-0002-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-010-0002-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T12:21:22Z","timestamp":1634905282000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12519-010-0002-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":148,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["2"],"URL":"https:\/\/doi.org\/10.1007\/s12519-010-0002-9","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}